Marinus Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Marinus Pharmaceuticals has scheduled its 2024 Annual Meeting for May 22, 2024, and is seeking stockholder votes on the election of directors, ratification of auditors, executive compensation, and approval of a new equity incentive plan.
DEF 14A: Marinus Pharmaceuticals Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Marinus Pharmaceuticals will hold its 2024 Annual Meeting of Stockholders virtually on May 22, 2024, to vote on director elections, auditor ratification, executive compensation, and an equity incentive plan.